Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Immunogen Inc. | 7 | 0 | 1 | 0 | €28.97 | - | - |
| Rigel Pharmaceutical Inc. | 9 | 0 | 0 | 0 | €1.02 | €13.74 | 1243.324% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.44 | €8.50 | 32.090% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.26 | €55.00 | 5.243% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €17.30 | €45.10 | 160.665% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €91.00 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €120.35 | €130.00 | 8.018% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €13.58 | €20.00 | 47.275% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.81 | - | - |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €46.58 | €70.00 | 50.295% |
| Eli Lilly Corp. | 47 | 0 | 4 | 0 | €685.20 | €753.63 | 9.987% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €44.60 | - | - |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.77 | €8.39 | 373.395% |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.79 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.75 | €65.00 | -4.059% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.85 | €12.09 | 553.481% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.64 | €4.63 | 625.596% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 3 | 1 | €4.70 | €12.80 | 172.372% |
| X4 Pharmaceuticals, Inc. | 4 | 1 | 1 | 1 | €1.09 | €2.76 | 153.003% |
| Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.00 | €51.20 | 50.581% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.50 | €85.64 | 39.258% |